Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soonmo Peter Kang

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
JOP : Journal of the Pancreas|March 10, 2011
Ampullary and periampullary tumors: translational efforts to meet a challenge in diagnosis and treatment. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011Soonmo Peter Kang, Muhammad Wasif Saif
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2010
Inconsistent labeling of food effect for oral agents across therapeutic areas: differences between oncology and non-oncology productsSoonmo Peter Kang, Mark J Ratain
JOP : Journal of the Pancreas|May 13, 2008
Pharmacogenomics and pancreatic cancer treatment. Optimizing current therapy and individualizing future therapySoonmo Peter Kang, Muhammad Wasif Saif
JOP : Journal of the Pancreas|July 6, 2010
Clinical outcome of pancreatic cancer patients with diabetes mellitus: is diabetes a poor prognostic factor? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010Soonmo Peter Kang, Muhammad Wasif Saif
Current Opinion in Obstetrics & Gynecology|January 17, 2008
Triple negative breast cancer: current understanding of biology and treatment optionsSoonmo Peter Kang, Maritza Martel, Lyndsay N Harris
World Journal of Gastroenterology|March 12, 2008
Pseudocirrhosis in a pancreatic cancer patient with liver metastases: a case report of complete resolution of pseudocirrhosis with an early recognition and managementSoonmo Peter Kang, Tamar Taddei, Bruce McLennan, et al.
JOP : Journal of the Pancreas|November 13, 2007
Long-term survival on capecitabine in two gemcitabine refractory pancreatic cancer patients. Is there a pharmacogenetic explanation?Muhammad Wasif Saif, Soonmo Peter Kang, Leslie Ledbetter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 25, 2015
Optimal Dosing for Targeted Therapies in Oncology: Drug Development Cases Leading by ExampleJeffrey R Sachs, Kapil Mayawala, Satvik Gadamsetty, et al.
The Pharmacogenomics Journal|April 22, 2009
Global variation in CYP2C8-CYP2C9 functional haplotypesWilliam C Speed, Soonmo Peter Kang, David P Tuck, et al.
Pharmacogenetics and Genomics|August 24, 2010
A pharmacogenetic study of vorinostat glucuronidationSoonmo Peter Kang, Jacqueline Ramirez, Larry House, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
JOP : Journal of the Pancreas|March 10, 2011
Ampullary and periampullary tumors: translational efforts to meet a challenge in diagnosis and treatment. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011Soonmo Peter Kang, Muhammad Wasif Saif
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2010
Inconsistent labeling of food effect for oral agents across therapeutic areas: differences between oncology and non-oncology productsSoonmo Peter Kang, Mark J Ratain
JOP : Journal of the Pancreas|May 13, 2008
Pharmacogenomics and pancreatic cancer treatment. Optimizing current therapy and individualizing future therapySoonmo Peter Kang, Muhammad Wasif Saif
JOP : Journal of the Pancreas|July 6, 2010
Clinical outcome of pancreatic cancer patients with diabetes mellitus: is diabetes a poor prognostic factor? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010Soonmo Peter Kang, Muhammad Wasif Saif
Current Opinion in Obstetrics & Gynecology|January 17, 2008
Triple negative breast cancer: current understanding of biology and treatment optionsSoonmo Peter Kang, Maritza Martel, Lyndsay N Harris
World Journal of Gastroenterology|March 12, 2008
Pseudocirrhosis in a pancreatic cancer patient with liver metastases: a case report of complete resolution of pseudocirrhosis with an early recognition and managementSoonmo Peter Kang, Tamar Taddei, Bruce McLennan, et al.
JOP : Journal of the Pancreas|November 13, 2007
Long-term survival on capecitabine in two gemcitabine refractory pancreatic cancer patients. Is there a pharmacogenetic explanation?Muhammad Wasif Saif, Soonmo Peter Kang, Leslie Ledbetter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 25, 2015
Optimal Dosing for Targeted Therapies in Oncology: Drug Development Cases Leading by ExampleJeffrey R Sachs, Kapil Mayawala, Satvik Gadamsetty, et al.
The Pharmacogenomics Journal|April 22, 2009
Global variation in CYP2C8-CYP2C9 functional haplotypesWilliam C Speed, Soonmo Peter Kang, David P Tuck, et al.
Pharmacogenetics and Genomics|August 24, 2010
A pharmacogenetic study of vorinostat glucuronidationSoonmo Peter Kang, Jacqueline Ramirez, Larry House, et al.
Pageof 2